In Vivo Efficacy of Imatinib Mesylate, a Tyrosine Kinase Inhibitor, in the Treatment of Chemically Induced Dry Eye in Animal Models-Reference-Cited by-同舟云学术

In Vivo Efficacy of Imatinib Mesylate, a Tyrosine Kinase Inhibitor, in the Treatment of Chemically Induced Dry Eye in Animal Models

Published:2021-09-14 Issue:11 Volume:10 Page:14
ISSN:2164-2591
Container-title:Translational Vision Science & Technology
language:en
Short-container-title:Trans. Vis. Sci. Tech.

Author:

Baek Yi-Yong¹,Sung Bokyung¹,Choi Jun-Sub¹,Go Hyeon-Kyu²,Kim Do-Hyung²,Hyon Joon Young³,You Ji Chang¹⁴

Affiliation:

1. Avixgen Inc., Seoul, Republic of Korea

2. KNOTUS Co. Ltd., Incheon, Republic of Korea

3. Department of Ophthalmology, Seoul National University College of Medicine, Seoul National University Bundang Hospital, Seongnam, Republic of Korea

4. National Research Laboratory for Molecular Virology, Department of Pathology, School of Medicine, The Catholic University of Korea, Seoul, Republic of Korea

Publisher

Association for Research in Vision and Ophthalmology (ARVO)

Subject

Ophthalmology,Biomedical Engineering

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A highly selective inhibitor of discoidin domain receptor‐1 (DDR1‐IN‐1) protects corneal epithelial cells from YAP/ACSL4‐mediated ferroptosis in dry eye;British Journal of Pharmacology;2024-07-08

2. Imatinib@glycymicelles entrapped in hydrogel: preparation, characterization, and therapeutic effect on corneal alkali burn in mice;Drug Delivery and Translational Research;2024-03-17

3. Corneal Melt Associated With Cancer Immunotherapy;Cornea Open;2023-03

4. Evaluation of effect of nilotinib in an experimental corneal neovascularization model;Anatolian Current Medical Journal;2022-10-22

5. Safety, tolerability, and pharmacokinetics of single and multiple topical ophthalmic administration of imatinib mesylate in healthy subjects;Clinical and Translational Science;2022-02-08